Our findings reveal a significant association between elevated MRPL37 expression and an advanced pathological T stage, suggesting that higher MRPL37 expression is correlated with greater malignancy and progression of HCC (Table S2). This evidence concerns the gene MRPL37 and hepatocellular carcinoma.